Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Relay Therapeutics Inc (NASDAQ: RLAY) was $4.47 for the day, down -1.54% from the previous closing price of $4.54. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 0.93 million shares were traded. RLAY stock price reached its highest trading level at $4.675 during the session, while it also had its lowest trading level at $4.44.
Ratios:
Our analysis of RLAY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 29 ’25 when Rahmer Peter sold 26,541 shares for $4.55 per share. The transaction valued at 120,762 led to the insider holds 419,681 shares of the business.
Rahmer Peter sold 17,250 shares of RLAY for $76,245 on Jan 30 ’25. The insider now owns 402,431 shares after completing the transaction at $4.42 per share. On Jan 28 ’25, another insider, Rahmer Peter, who serves as the insider of the company, sold 1,673 shares for $4.63 each. As a result, the insider received 7,746 and left with 307,081 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 748201984 and an Enterprise Value of -41592176. For the stock, the TTM Price-to-Sale (P/S) ratio is 74.75 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at -4.157 whereas that against EBITDA is 0.107.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.62, which has changed by -0.48561567 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $11.16, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is -1.76%, while the 200-Day Moving Average is calculated to be -29.54%.
Shares Statistics:
RLAY traded an average of 2.39M shares per day over the past three months and 2207330 shares per day over the past ten days. A total of 166.89M shares are outstanding, with a floating share count of 123.82M. Insiders hold about 26.02% of the company’s shares, while institutions hold 73.16% stake in the company. Shares short for RLAY as of 1736899200 were 15208884 with a Short Ratio of 6.35, compared to 1734048000 on 12081421. Therefore, it implies a Short% of Shares Outstanding of 15208884 and a Short% of Float of 11.020000000000001.
